The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,3S)-3-((S)-2-((S)-2-acetamido-3-(1-(8-phenyloctyl)-1H-imidazol-5-yl)propanamido)-3-hydroxypropanamido)-4-amino-4-oxobutan-2-yl dihydrogen phosphate ID: ALA4285090
PubChem CID: 71468090
Max Phase: Preclinical
Molecular Formula: C29H45N6O9P
Molecular Weight: 652.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O
Standard InChI: InChI=1S/C29H45N6O9P/c1-20(44-45(41,42)43)26(27(30)38)34-29(40)25(18-36)33-28(39)24(32-21(2)37)16-23-17-31-19-35(23)15-11-6-4-3-5-8-12-22-13-9-7-10-14-22/h7,9-10,13-14,17,19-20,24-26,36H,3-6,8,11-12,15-16,18H2,1-2H3,(H2,30,38)(H,32,37)(H,33,39)(H,34,40)(H2,41,42,43)/t20-,24+,25+,26+/m1/s1
Standard InChI Key: RLKOZTUQTILVBD-CHQQOIJLSA-N
Molfile:
RDKit 2D
45 46 0 0 0 0 0 0 0 0999 V2000
4.2603 -14.3646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6820 -14.3667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9709 -14.7777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9699 -15.5925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6791 -15.9971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3909 -15.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1027 -15.9971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3909 -14.7672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8146 -15.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5264 -15.9971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8146 -14.7672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5264 -14.3545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2382 -15.5885 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5264 -16.8185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9501 -15.9971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6619 -15.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3696 -15.9971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6619 -14.7672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9501 -16.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2382 -17.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6619 -17.2312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6619 -18.0525 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
11.3696 -18.4611 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9501 -18.4611 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3664 -17.6315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6791 -16.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9714 -17.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2229 -16.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6720 -17.5071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0847 -18.2190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8881 -18.0489 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4961 -18.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2730 -18.3416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8809 -18.8876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6578 -18.6342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2658 -19.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0427 -18.9268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6506 -19.4728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4817 -20.2724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0896 -20.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9153 -21.6172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5225 -22.1630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3003 -21.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4676 -21.1055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8591 -20.5632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
1 3 1 0
3 2 2 0
5 6 1 0
6 7 1 0
6 8 2 0
7 9 1 0
9 10 1 0
9 11 1 1
11 12 1 0
10 13 1 0
10 14 2 0
13 15 1 0
15 16 1 6
16 17 1 0
16 18 2 0
15 19 1 0
19 20 1 6
19 21 1 0
21 22 1 0
22 23 1 0
22 24 2 0
22 25 1 0
5 4 1 0
5 26 1 6
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 27 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
40 41 2 0
41 42 1 0
42 43 2 0
43 44 1 0
44 45 2 0
45 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 652.69Molecular Weight (Monoisotopic): 652.2986AlogP: 0.46#Rotatable Bonds: 21Polar Surface Area: 235.20Molecular Species: ACIDHBA: 9HBD: 7#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 8#RO5 Violations (Lipinski): 3CX Acidic pKa: 1.35CX Basic pKa: 6.51CX LogP: -2.06CX LogD: -3.64Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.07Np Likeness Score: -0.03
References 1. Hymel D, Grant RA, Tsuji K, Yaffe MB, Burke TR.. (2018) Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors., 28 (19): [PMID:30174151 ] [10.1016/j.bmcl.2018.08.018 ]